Next Article in Journal
COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing
Next Article in Special Issue
Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies
Previous Article in Journal
Risk Analysis by Age on the Burden of Meningococcal Disease in Spain
Previous Article in Special Issue
The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines
 
 
Review

Article Versions Notes

Vaccines 2022, 10(4), 593; https://doi.org/10.3390/vaccines10040593
Action Date Notes Link
article xml file uploaded 12 April 2022 12:16 CEST Original file -
article xml uploaded. 12 April 2022 12:16 CEST Update -
article pdf uploaded. 12 April 2022 12:16 CEST Version of Record https://www.mdpi.com/2076-393X/10/4/593/pdf-vor
article html file updated 12 April 2022 12:17 CEST Original file -
article xml file uploaded 14 April 2022 03:49 CEST Update -
article xml uploaded. 14 April 2022 03:49 CEST Update -
article pdf uploaded. 14 April 2022 03:49 CEST Updated version of record https://www.mdpi.com/2076-393X/10/4/593/pdf-vor
article html file updated 14 April 2022 03:50 CEST Update -
article xml file uploaded 14 April 2022 03:56 CEST Update -
article xml uploaded. 14 April 2022 03:56 CEST Update https://www.mdpi.com/2076-393X/10/4/593/xml
article pdf uploaded. 14 April 2022 03:56 CEST Updated version of record https://www.mdpi.com/2076-393X/10/4/593/pdf
article html file updated 14 April 2022 03:58 CEST Update -
article html file updated 2 August 2022 18:26 CEST Update https://www.mdpi.com/2076-393X/10/4/593/html
Back to TopTop